ClinicalTrials.Veeva

Menu

AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease (POWER CAD I)

A

Amplitude Vascular Systems

Status

Not yet enrolling

Conditions

Coronary Arterial Disease (CAD)

Treatments

Device: Pulse Intravascular Lithotripsy (Pulse IVL)

Study type

Interventional

Funder types

Industry

Identifiers

NCT07510438
CL-00014

Details and patient eligibility

About

A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • ≥ 18 years of age
  • Subjects with native coronary artery disease
  • Left ventricular ejection fraction (LVEF) ≥ 35% within 6 months
  • The target lesion must be a single de novo coronary lesion
  • The target lesion stenosis of left anterior descending artery (LAD), right coronary artery (RCA), left circumflex artery (LCX), or ramus intermedius (RI), or of their branches with Stenosis of ≥70% and <100% or Stenosis ≥50% and <70% with evidence of ischemia
  • Lesion length must not exceed 44 mm

Key Exclusion Criteria:

  • Subject experienced an acute Myocardial Infarction (MI), either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) within 30 days prior to index procedure.
  • Subject has New York Heart Association (NYHA) class III or IV heart failure.
  • Subject has renal failure with serum creatinine >2.5 mg/dL, or chronic dialysis.
  • Subject has a previous stent in the target vessel implanted within last six months.
  • Unprotected LMCA diameter stenosis >30%.
  • Target lesion has a myocardial bridge.
  • Target vessel is excessively tortuous, defined as the presence of 2 or more bends >90 degrees or 3 or more bends >75 degrees.
  • Evidence of aneurysm in target vessel within 10 mm of the target lesion.
  • Target lesion in ostial location (LAD, RCA, LCX, or RI, within 5 mm of ostium) or in an unprotected LMCA.
  • Target lesion is a bifurcation with ostial diameter stenosis ≥30%.
  • Any previous stent within 10 mm of the target lesion.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Pulse Intravascular Lithotripsy™ (Pulse IVL™)
Experimental group
Description:
Pulse Intravascular Lithotripsy™ (Pulse IVL™) to open vessels with calcific walls
Treatment:
Device: Pulse Intravascular Lithotripsy (Pulse IVL)

Trial contacts and locations

0

Loading...

Central trial contact

Elise Gendreau; Elizabeth Galle

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems